Baird Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,634
| Closed | -$4.82M | – | 1753 |
|
|
2024
Q2 | $4.82M | Buy |
17,634
+1,542
| +10% | +$421K | 0.01% | 676 |
|
|
2024
Q1 | $5.57M | Buy |
16,092
+3,921
| +32% | +$1.36M | 0.01% | 632 |
|
|
2023
Q4 | $3.93M | Sell |
12,171
-1,700
| -12% | -$549K | 0.01% | 732 |
|
|
2023
Q3 | $4.97M | Buy |
13,871
+1,034
| +8% | +$371K | 0.01% | 628 |
|
|
2023
Q2 | $4.87M | Buy |
12,837
+10,077
| +365% | +$3.82M | 0.01% | 630 |
|
|
2023
Q1 | $1.32M | Buy |
2,760
+367
| +15% | +$176K | ﹤0.01% | 1018 |
|
|
2022
Q4 | $1.01M | Buy |
2,393
+88
| +4% | +$37K | ﹤0.01% | 1065 |
|
|
2022
Q3 | $962K | Buy |
2,305
+126
| +6% | +$52.6K | ﹤0.01% | 1063 |
|
|
2022
Q2 | $1.08M | Buy |
2,179
+184
| +9% | +$91K | ﹤0.01% | 1053 |
|
|
2022
Q1 | $1.12M | Buy |
1,995
+203
| +11% | +$114K | ﹤0.01% | 1098 |
|
|
2021
Q4 | $1.35M | Buy |
1,792
+293
| +20% | +$221K | ﹤0.01% | 1089 |
|
|
2021
Q3 | $1.12M | Buy |
1,499
+1,048
| +232% | +$782K | ﹤0.01% | 1161 |
|
|
2021
Q2 | $291K | Sell |
451
-54
| -11% | -$34.8K | ﹤0.01% | 1583 |
|
|
2021
Q1 | $289K | Buy |
+505
| New | +$289K | ﹤0.01% | 1534 |
|
|
2019
Q4 | – | Sell |
-7,099
| Closed | -$2.36M | – | 1509 |
|
|
2019
Q3 | $2.36M | Buy |
+7,099
| New | +$2.36M | 0.01% | 726 |
|